Genpact Reports First Quarter 2020 Results
"I am extremely proud of the passion and dedication of the
Key Financial Results – First Quarter 2020
- Total revenue was
$923 million , up 14% year-over-year both on an as reported and constant currency basis.1 - Revenue from Global Clients was
$802 million , up 14% year-over-year (15% on a constant currency basis),1 representing 87% of total revenue. - Revenue from
GE was$122 million , up 12% year-over-year, representing 13% of total revenue. - Net income attributable to
Genpact Limited shareholders was$86 million , up 41% year-over-year, with a corresponding margin of 9.3%. - Income from operations was
$111 million , up 23% year-over-year, with a corresponding margin of 12.0%. Adjusted income from operations was$136 million , up 12% year-over-year, with a corresponding margin of 14.7%.3 - Diluted earnings per share was
$0.44 , up 42% year-over-year, and adjusted diluted earnings per share2 was$0.53 , up 23% year-over-year. - Cash utilized in operations was
$19 million , compared to$5 million in the first quarter of 2019.
2020 Outlook
Due to the impact of COVID-19, the company is currently anticipating second quarter revenue to be down 4% to 6% year-over-year, or down 3% to 5% on a constant currency basis.1
Due to the uncertainty caused by COVID-19, the company has decided to withdraw its 2020 financial outlook issued on
Conference Call to Discuss Financial Results
A live webcast of the call will also be made available on the Genpact Investor Relations website at https://www.genpact.com/investors. For those who cannot join the call live, a replay will be archived on the
About
Safe Harbor
This press release contains certain statements concerning our future growth prospects and financial results and other forward-looking statements, as defined in the safe harbor provisions of the
Contacts
Investors |
|
|
+1 (203) 808-6725 |
||
Media |
|
|
+1 (217) 260-5041 |
||
GENPACT LIMITED AND ITS SUBSIDIARIES |
||||||
Consolidated Balance Sheets |
||||||
(Unaudited) |
||||||
(In thousands, except per share data and share count) |
||||||
As of December 31, |
As of |
|||||
2019 |
2020 |
|||||
Assets |
||||||
Current assets |
||||||
Cash and cash equivalents |
$ |
467,096 |
$ |
401,624 |
||
Accounts receivable, net of reserve for doubtful receivables of |
914,255 |
910,955 |
||||
Prepaid expenses and other current assets |
170,325 |
166,358 |
||||
Total current assets |
$ |
1,551,676 |
$ |
1,478,937 |
||
Property, plant and equipment, net |
254,035 |
245,800 |
||||
Operating lease right-of-use assets |
330,854 |
342,377 |
||||
Deferred tax assets |
89,715 |
102,078 |
||||
Intangible assets, net |
230,861 |
215,036 |
||||
|
1,574,466 |
1,554,679 |
||||
Contract cost assets |
205,498 |
211,066 |
||||
Other assets, net of reserve for doubtful assets of |
217,079 |
252,807 |
||||
Total assets |
$ |
4,454,184 |
$ |
4,402,780 |
||
Liabilities and equity |
||||||
Current liabilities |
||||||
Short-term borrowings |
$ |
70,000 |
$ |
165,000 |
||
Current portion of long-term debt |
33,509 |
33,517 |
||||
Accounts payable |
21,981 |
26,070 |
||||
Income taxes payable |
43,186 |
47,225 |
||||
Accrued expenses and other current liabilities |
683,871 |
611,145 |
||||
Operating leases liability |
57,664 |
61,100 |
||||
Total current liabilities |
$ |
910,211 |
$ |
944,057 |
||
Long-term debt, less current portion |
1,339,796 |
1,331,689 |
||||
Operating leases liability |
302,100 |
310,829 |
||||
Deferred tax liabilities |
3,990 |
3,333 |
||||
Other liabilities |
208,916 |
239,793 |
||||
Total liabilities |
$ |
2,765,013 |
$ |
2,829,701 |
||
Shareholders' equity |
||||||
Preferred shares, |
— |
— |
||||
Common shares, 190,118,181 and 190,201,079 issued and outstanding as of |
1,896 |
1,898 |
||||
Additional paid-in capital |
1,570,575 |
1,566,191 |
||||
Retained earnings |
648,656 |
666,816 |
||||
Accumulated other comprehensive income (loss) |
(531,956) |
(661,826) |
||||
Total equity |
$ |
1,689,171 |
$ |
1,573,079 |
||
Total liabilities and equity |
$ |
4,454,184 |
$ |
4,402,780 |
GENPACT LIMITED AND ITS SUBSIDIARIES |
||||||
Consolidated Statements of Income |
||||||
(Unaudited) |
||||||
(In thousands, except per share data and share count) |
||||||
Three months ended |
||||||
2019 |
2020 |
|||||
Net revenues |
$ |
809,206 |
$ |
923,192 |
||
Cost of revenue |
519,137 |
604,771 |
||||
Gross profit |
$ |
290,069 |
$ |
318,421 |
||
Operating expenses: |
||||||
Selling, general and administrative expenses |
191,402 |
197,342 |
||||
Amortization of acquired intangible assets |
8,509 |
10,741 |
||||
Other operating (income) expense, net |
86 |
(320) |
||||
Income from operations |
$ |
90,072 |
$ |
110,658 |
||
Foreign exchange gains (losses), net |
(3,432) |
14,531 |
||||
Interest income (expense), net |
(11,123) |
(11,696) |
||||
Other income (expense), net |
3,803 |
(2,934) |
||||
Income before equity-method investment activity, net and income tax expense |
$ |
79,320 |
$ |
110,559 |
||
Equity-method investment activity, net |
4 |
— |
||||
Income before income tax expense |
$ |
79,324 |
$ |
110,559 |
||
Income tax expense |
18,483 |
24,861 |
||||
Net income attributable to |
$ |
60,841 |
$ |
85,698 |
||
Net income available to |
$ |
60,841 |
$ |
85,698 |
||
Earnings per common share attributable to |
||||||
Basic |
$ |
0.32 |
$ |
0.45 |
||
Diluted |
$ |
0.31 |
$ |
0.44 |
||
Weighted average number of common shares used in computing earnings per common share attributable to |
||||||
Basic |
189,451,845 |
190,626,757 |
||||
Diluted |
193,394,208 |
196,532,513 |
GENPACT LIMITED AND ITS SUBSIDIARIES |
||||||
Consolidated Statements of Cash Flows |
||||||
(Unaudited) |
||||||
(In thousands) |
||||||
Three months ended |
||||||
2019 |
2020 |
|||||
Operating activities |
||||||
Net income attributable to |
$ |
60,841 |
$ |
85,698 |
||
Adjustments to reconcile net income to net cash used for operating activities: |
||||||
Depreciation and amortization |
21,919 |
28,494 |
||||
Amortization of debt issuance costs (including loss on extinguishment of debt) |
443 |
561 |
||||
Amortization of acquired intangible assets |
8,509 |
10,741 |
||||
Reserve for doubtful receivables/allowance for credit losses |
2,026 |
2,156 |
||||
Unrealized loss (gain) on revaluation of foreign currency asset/liability |
257 |
(9,655) |
||||
Stock-based compensation expense |
18,461 |
17,487 |
||||
Deferred tax expense (benefit) |
(5,522) |
(392) |
||||
Others, net |
(508) |
(348) |
||||
Change in operating assets and liabilities: |
||||||
Increase in accounts receivable |
(64,763) |
(3,858) |
||||
Increase in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets |
(36,220) |
(84,098) |
||||
Increase (decrease) in accounts payable |
(12,189) |
4,557 |
||||
Decrease in accrued expenses, other current liabilities, operating leases liability and other liabilities |
(12,087) |
(74,788) |
||||
Increase in income taxes payable |
13,417 |
4,796 |
||||
Net cash used for operating activities |
$ |
(5,416) |
$ |
(18,649) |
||
Investing activities |
||||||
Purchase of property, plant and equipment |
(14,072) |
(20,956) |
||||
Payment for internally generated intangible assets (including intangibles under development) |
(7,914) |
(3,236) |
||||
Proceeds from sale of property, plant and equipment |
1,478 |
312 |
||||
Payment for business acquisitions, net of cash acquired |
(6,305) |
— |
||||
Net cash used for investing activities |
$ |
(26,813) |
$ |
(23,880) |
||
Financing activities |
||||||
Repayment of finance lease obligations |
(1,780) |
(1,950) |
||||
Payment of debt issuance costs |
— |
(620) |
||||
Repayment of long-term debt |
(8,500) |
(8,500) |
||||
Proceeds from short-term borrowings |
50,000 |
125,000 |
||||
Repayment of short-term borrowings |
(25,000) |
(30,000) |
||||
Proceeds from issuance of common shares under stock-based compensation plans |
4,599 |
4,063 |
||||
Payment for net settlement of stock-based awards |
(652) |
(26,238) |
||||
Payment of earn-out consideration |
(8,400) |
— |
||||
Dividend paid |
(16,119) |
(18,543) |
||||
Payment for stock repurchased and retired |
— |
(45,000) |
||||
Payment for expenses related to stock repurchase |
— |
(21) |
||||
Net cash used for financing activities |
$ |
(5,852) |
$ |
(1,809) |
||
Effect of exchange rate changes |
(4,938) |
(21,134) |
||||
Net decrease in cash and cash equivalents |
(38,081) |
(44,338) |
||||
Cash and cash equivalents at the beginning of the period |
368,396 |
467,096 |
||||
Cash and cash equivalents at the end of the period |
$ |
325,377 |
$ |
401,624 |
||
Supplementary information |
||||||
Cash paid during the period for interest |
$ |
8,486 |
$ |
5,295 |
||
Cash paid during the period for income taxes, net of refund |
$ |
19,286 |
$ |
69,357 |
||
Right-of-use assets acquired under finance lease obligations |
$ |
1,433 |
$ |
10,353 |
Non-GAAP Financial Measures
To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:
- Adjusted income from operations attributable to shareholders of
Genpact Limited , or adjusted income from operations; - Adjusted income from operations margin;
- Adjusted diluted earnings per share attributable to shareholders of
Genpact Limited , or adjusted diluted earnings per share; and - Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of
Prior to
Accordingly,
A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income attributable to
The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the three months ended
Reconciliation of Net income attributable to |
||||||||
(Unaudited) |
||||||||
(In thousands) |
||||||||
Three months ended |
||||||||
2019 |
2020 |
|||||||
Net income attributable to |
$ |
60,841 |
$ |
85,698 |
||||
Foreign exchange (gains) losses, net |
3,432 |
(14,531) |
||||||
Interest (income) expense, net |
11,123 |
11,696 |
||||||
Income tax expense |
18,483 |
24,861 |
||||||
Stock-based compensation expense |
18,461 |
17,487 |
||||||
Amortization of acquired intangible assets |
8,204 |
10,514 |
||||||
Acquisition-related expenses |
967 |
- |
||||||
Adjusted income from operations |
$ |
121,511 |
$ |
135,725 |
||||
Net income attributable to |
7.5 |
% |
9.3 |
% |
||||
Adjusted income from operations margin |
15.0 |
% |
14.7 |
% |
Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin |
||||||||
(Unaudited) |
||||||||
(In thousands) |
||||||||
Three months ended |
||||||||
2019 |
2020 |
|||||||
Income from operations |
$ |
90,072 |
$ |
110,658 |
||||
Stock-based compensation expense |
18,461 |
17,487 |
||||||
Amortization of acquired intangible assets |
8,204 |
10,514 |
||||||
Acquisition-related expenses |
967 |
- |
||||||
Other income (expense), net |
3,803 |
(2,934) |
||||||
Equity-method investment activity, net |
4 |
- |
||||||
Adjusted income from operations |
$ |
121,511 |
$ |
135,725 |
||||
Income from operations margin |
11.1 |
% |
12.0 |
% |
||||
Adjusted income from operations margin |
15.0 |
% |
14.7 |
% |
Reconciliation of Diluted EPS to Adjusted Diluted EPS4 |
||||||
(Unaudited) |
||||||
(Per share data) |
||||||
Three months ended |
||||||
2019 |
2020 |
|||||
Diluted EPS |
$ |
0.31 |
$ |
0.44 |
||
Stock-based compensation expense |
0.10 |
0.09 |
||||
Amortization of acquired intangible assets |
0.04 |
0.05 |
||||
Acquisition-related expenses |
0.00 |
- |
||||
Tax impact on stock-based compensation |
(0.02) |
(0.04) |
||||
Tax impact on amortization of acquired intangible assets |
(0.01) |
(0.01) |
||||
Tax impact on acquisition-related expenses |
(0.00) |
- |
||||
Adjusted diluted EPS |
$ |
0.43 |
$ |
0.53 |
1Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period's foreign currency exchange rates adjusted for hedging gains/losses in such period.
2Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.
3Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from operations and GAAP net income attributable to
4 Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.
View original content to download multimedia:http://www.prnewswire.com/news-releases/genpact-reports-first-quarter-2020-results-301056948.html
SOURCE